Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Revenue

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Net Sales ₹263 Cr₹224 Cr₹220 Cr₹185 Cr₹184 Cr

What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?

The latest Revenue ratio of SYNCOM FORMULATIONS (INDIA) is ₹263 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹263 Cr
Mar2023₹224 Cr
Mar2022₹220 Cr
Mar2017₹185 Cr
Mar2016₹184 Cr

How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?

Years Revenue % Change
Mar2024 ₹263 Cr
17.45
Mar2023 ₹224 Cr
2.09
Mar2022 ₹220 Cr
18.85
Mar2017 ₹185 Cr
0.50
Mar2016 ₹184 Cr -

Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,549.1 Cr 4.4% -1.1% 23.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,971.0 Cr -4.6% 0.7% 10.8% Stock Analytics
DIVIS LABORATORIES ₹161,153.0 Cr -1.2% 12.6% 51.2% Stock Analytics
CIPLA ₹122,717.0 Cr 0.7% 6% 9.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,392.0 Cr -1.8% -0.4% 25.1% Stock Analytics
DR REDDYS LABORATORIES ₹100,702.0 Cr 4% 8.9% -1.3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

4.4%

-1.1%

23.3%

SENSEX

0.6%

11%

10.4%


You may also like the below Video Courses